Skip to main content

Diagnosis and screening

Diagnosis and screening

Coronary artery plaque

17-05-2022 | Systemic lupus erythematosus | News

Vascular plaque burden could predict future CVD risk in people with SLE

The overall burden of vascular plaque measured on ultrasound scans is significantly associated with future risk for cardiovascular disease events in people with systemic lupus erythematosus, study findings indicate.

Rituximab and rheumatology practice in the COVID-19 era

Rituximab and rheumatology practice in the COVID-19 era

How can rheumatologists respond to the challenges associated with rituximab use during the pandemic?

06-01-2022 | Systemic lupus erythematosus | News

Poor perinatal outcome risk evident before SLE diagnosis in African–American women

African–American women with systemic lupus erythematosus have an increased risk for delivering preterm or small for gestational age infants, even in the years immediately before their diagnosis, US study findings indicate.

22-10-2021 | Dermatomyositis | News

New EULAR/ACR dermatomyositis criteria shed light on disease frequency, mortality

A population-based cohort study using the 2017 EULAR/American College of Rheumatology criteria for dermatomyositis has identified a higher incidence, prevalence, and associated mortality rate than previously reported.

Antibodies (illustration)

23-09-2021 | Myositis | News

Myositis-specific autoantibodies could aid inflammatory myopathy classification

Some subgroups of patients with myositis-specific autoantibody positive inflammatory myopathies are “frequently misclassified” based on currently used criteria, and adopting an autoantibody-based system may improve classification, researchers report.

Anifrolumab for the treatment of lupus

Anifrolumab for the treatment of SLE

Perspective on the approval of anifrolumab and the importance of endpoints in lupus trials.

New additions to the Adis Journal Club

Adis Journal Club

A monthly selection of topical peer-reviewed articles from the Adis journals, curated by the editors.

JAK inhibitor safety

Data summary, expert discussion, & research news on the potential risks associated with JAK inhibitors.

ACR Convergence 2021 highlights

ACR Convergence 2021

3–9 November: Keep up with the latest news and interviews from the conference.

Febuxostat and cardiovascular risk in people with gout

Febuxostat and cardiovascular risk in people with gout

How will the FAST trial results impact regulatory guidance & clinical practice?

Telemedicine in rheumatology

Telemedicine in rheumatology: COVID-19 and beyond

Experts discuss the increasing use of telemedicine in rheumatology during the COVID-19 pandemic.

Get ready for ACR Convergence 2020

ACR Convergence 2020

5 – 9 November: Preview the conference with session recommendations and updates on upcoming coverage.

11-06-2020 | EULAR 2020 | Conference coverage | News

Quantitative computed tomography predicts 10-year mortality risk in SSc–ILD

Quantitative computed tomography analysis has the potential to identify patients with systemic sclerosis-associated interstitial lung disease with a high 10-year mortality risk

Do myositis-specific antibodies have an impact on the treatment of idiopathic inflammatory myopathies?

Do myositis-specific antibodies have an impact on the treatment of idiopathic inflammatory myopathies?

Latika Gupta and Rohit Aggarwal evaluate the use of myositis-specific antibodies in the classification and management of this disease.

Antibodies

15-01-2020 | Myositis | Editorial | Article

Do myositis-specific antibodies have an impact on the treatment of idiopathic inflammatory myopathies?

Latika Gupta and Rohit Aggarwal evaluate the use of myositis-specific antibodies in the classification and management of this disease.

Neuropsychiatric systemic lupus erythematosus: Issues in diagnosis and management

Neuropsychiatric systemic lupus erythematosus: Issues in diagnosis and management

Antigone Pieta, Dionysis Nikolopoulos, and Antonis Fanouriakis discuss the causes and management of neuropsychiatric systemic lupus erythematosus, and outline unmet needs in the diagnosis and treatment of this disease.

Human brain digital illustration

13-08-2019 | Systemic lupus erythematosus | Editorial | Article

Neuropsychiatric systemic lupus erythematosus: Issues in diagnosis and management

Antigone Pieta, Dionysis Nikolopoulos, and Antonis Fanouriakis discuss the causes and management of neuropsychiatric systemic lupus erythematosus, and outline unmet needs in the diagnosis and treatment of this disease.

11-12-2018 | Systemic lupus erythematosus | Article

New therapeutic strategies in systemic lupus erythematosus management

Gatto M et al. Nat Rev Rheum 2018. doi: 10.1038/s41584-018-0133-2

25-09-2018 | Sjögren’s syndrome | Article

Clinical and immunological features of anti-centromere antibody-positive primary Sjögren’s syndrome

Tsukamoto M, Suzuki K, Takeuchi T. Rheumatol Ther 2018. doi: 10.1007/s40744-018-0126-2